Brick & Kyle, Associates Gsk PLC Transaction History

Brick & Kyle, Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jun 13, 2019	SELL	$37.8 - $42.69 $8,505 - $9,605	-225 Reduced 0.57%	39,502 $1.54 Million
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $93,083 - $100,486	-2,350 Reduced 5.58%	39,727 $1.6 Million
Q1 2018 May 10, 2018	SELL	$36.18 - $40.15 $5,499 - $6,102	-152 Reduced 0.36%	42,077 $1.64 Million
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $1.67 Million - $1.75 Million	42,229	42,229 $1.71 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Brick & Kyle, Associates, based on Form 13F filings with the SEC.

Stay updated on Brick & Kyle, Associates with notifications on news.